# CHEMANEX PLC Financial Summary

Canonical URL: https://pal.lk/updates/chmx-financial-summary
Symbol: CHMX.N0000
Company: CHEMANEX PLC
Sector: Materials
Published: 2026-07-27T04:27:49Z
Last updated: 2026-07-27T04:27:49Z

# Chemanex PLC Financial Summary and Investment Analysis

## Executive Overview
Chemanex PLC is a manufacturer and distributor of value-added specialty compounds and intermediates, operating primarily in rubber, coatings, home and personal care, and packaging sectors. The company has been executing a deliberate strategic shift from generic, price-sensitive chemicals towards specialized, performance-oriented technical solutions. Over the analyzed periods, Chemanex demonstrated a robust financial recovery and operational outperformance relative to the broader market, significantly expanding its top-line revenue and profitability. The company operates with a lean organizational structure while leveraging the back-office support of its parent company, CIC Holdings PLC. A defining characteristic of Chemanex is its massive equity investment portfolio, which constitutes the vast majority of its total asset base.

- **Key periods covered**: Q3 2023 to Q1 2026 (Calendar Year mapping based on period end dates up to March 31, 2026).

## Financial Performance
## Revenue and Profitability Trends

| Period | Revenue (Rs.'000) | Gross Profit (Rs.'000) | Net Profit/Loss (Rs.'000) | GP Margin | NP Margin |
|--------|-------------------|------------------------|---------------------------|-----------|-----------|
| **12 Months ended Q1 2026** | 1,092,939 | 289,573 | 163,242 | 26.49% | 14.93% |
| **12 Months ended Q1 2025** | 873,516 | 252,055 | 118,613 | 28.85% | 13.58% |
| **12 Months ended Q1 2024** | 788,965 | 188,561 | 111,379 | 23.90% | 14.11% |
| Q1 2026 | 267,624 | 77,439 | 59,336 | 28.93% | 22.17% |
| Q4 2024 | 310,457 | 81,034 | 43,767 | 26.10% | 14.10% |
| Q3 2024 | 285,413 | 75,540 | 25,252 | 26.46% | 8.84% |
| Q2 2024 | 173,432 | 49,366 | 44,072 | 28.46% | 25.41% |
| Q1 2024 | 224,178 | 46,281 | 53,412 | 20.64% | 23.82% |
| Q4 2023 | 217,477 | 49,729 | 43,189 | 22.86% | 19.85% |
| Q3 2023 | 183,812 | 47,289 | 2,294 | 25.72% | 1.24% |

**Analysis**: 
Chemanex exhibited excellent year-over-year growth, with revenue for the 12 months ended Q1 2026 increasing by 25.12% compared to the prior year. Profitability expanded at an even faster rate, with net profit increasing by 37.61% YoY. This acceleration indicates strong operational leverage, driven by an improved product mix as specialty chemicals grew to account for 50% of business volumes (up from 30% previously). The company also reported enhanced cost controls and disciplined capital deployment. The Paints and Coatings segment and the Rubber segment were the strongest contributors to the top line.

## Balance Sheet Analysis
Chemanex's balance sheet is highly atypical for a standard trading/manufacturing company; it functions significantly as an investment holding entity. 

| Balance Sheet Item (Rs.'000) | As of Q1 2026 | As of Q1 2025 | As of Q1 2024 |
|------------------------------|---------------|---------------|---------------|
| **Total Assets** | 4,647,052 | 4,458,188 | 3,882,907 |
| - *Equity Investments (FVOCI)*| 4,078,722 | 3,912,768 | 3,469,538 |
| - *Current Assets* | 3,797,821 | 3,993,948 | 3,516,404 |
| **Total Liabilities** | 443,874 | 372,443 | 270,298 |
| - *Total Debts / Borrowings* | 159,425 | 208,719 | 172,871 |
| **Total Equity** | 4,203,179 | 4,085,745 | 3,625,589 |

**Analysis**:
- **Asset Concentration**: Equity investments measured at Fair Value Through OCI account for roughly 87.7% of Total Assets. The portfolio includes major stakes in John Keells Holdings PLC (Rs. 3.25 Billion) and an unquoted strategic investment in CIC Feeds (Pvt) Ltd (Rs. 759 Million).
- **Liquidity**: The company operates with a tremendous Current Ratio of 13.55x (up from 12.37x in Q1 2025), though a vast portion of "Current Assets" is composed of its liquid equity investments. Actual cash and bank balances are relatively small compared to short-term borrowings, resulting in a net unfavourable cash and cash equivalent balance.
- **Solvency**: The debt-to-equity ratio is practically negligible at 3.79%. The company relies on short-term bank overdrafts and money market borrowings for operational liquidity rather than long-term debt.

## Cash Flow Analysis

| Cash Flow Summary (Rs.'000) | 12 Months to Q1 2026 | 12 Months to Q1 2025 | 12 Months to Q1 2024 |
|-----------------------------|----------------------|----------------------|----------------------|
| Net Cash from Operating Activities | 100,792 | 49,807 | 32,895 |
| Net Cash from Investing Activities | 13,156 | (19,105) | (292,788) |
| Net Cash from Financing Activities | (51,046) | (46,678) | (49,150) |
| **Net Change in Cash** | 62,902 | (15,976) | (309,043) |

**Analysis**:
Cash generated from operations doubled YoY, climbing to Rs. 100.79M by Q1 2026, driven by top-line growth and effective working capital management (working capital cycle improved from 146 days to 107 days). Investing cash flows swung positive due to the active management of the investment portfolio (Rs. 476M generated from disposals, offset by Rs. 527M in acquisitions, plus Rs. 61M in dividend income). The primary financing outflow was regular dividend payments to shareholders.

## Key Financial Ratios and Growth Indicators

| Metric | 12 Months to Q1 2026 | 12 Months to Q1 2025 | 12 Months to Q1 2024 |
|--------|----------------------|----------------------|----------------------|
| EPS (Rs.) | 10.11 | 7.55 | 7.09 |
| Net Asset Value per Share (Rs.) | 260.40 | 260.30 | 231.00 |
| ROE (%) | 3.88% | 2.90% | 3.07% |
| ROA (%) | 3.51% | 2.66% | 2.86% |
| P/E Ratio (x) | 15.68 | 20.39 | 10.16 |
| Dividend Yield (%) | 4.74% | 1.62% | 3.47% |
| Revenue YoY Growth | 25.12% | 10.71% | (34.82%) |

**Growth Indicators**:
- Increasing margin reliance on specialized chemical solutions, moving away from volume-driven generic price wars.
- Strategic intent to push the specialty product portfolio from 50% to 60% of total volume in the upcoming year.
- Consistent expansion in Earnings Per Share (EPS), driven by strong adjusted EBITDA growth (Rs. 226M in 12 months to Q1 2026).

## Economic and Market Context
The Sri Lankan macroeconomic environment displayed notable stabilization during the periods reviewed, rebounding from previous deflationary environments and achieving approximately 5% GDP growth. Industrial output (expanding ~6%) drove recovery in the manufacturing segment, creating favorable demand conditions for Chemanex's industrial raw materials. Declining interest rates expanded private sector credit, supporting domestic demand. Though temporary weather-related disruptions (cyclones) briefly disrupted plantation and coating segment output during winter months, overall business confidence heavily improved.

## Future Potential and Outlook
Management exhibits a confident outlook focused on deepening market penetration and defending margin profiles:
- **Portfolio Expansion**: Plans to onboard approximately five new suppliers across rubber, food additives, and coatings. 
- **Customer Mix Evolution**: Broadening the focus from exclusively large industrial accounts to aggressively targeting small and medium enterprises (SMEs) via technical workshops.
- **Product Development**: New pigment grades tailored for export-oriented rubber manufacturers are gaining traction, and new opportunities in dairy and confectionery segments are being actively explored.

## Risks and Challenges
- **Geopolitical and Supply Chain Volatility**: Conflict in the Middle East and general geopolitical tensions pose threats to global supply chains and commodity input pricing.
- **Macro-Economic Sensitivity**: The domestic construction and rubber retreading segments remain subdued. Changes in Sri Lankan import/export regulations could alter competitive dynamics.
- **Low Operating Asset Base vs Total Capital**: The company's massive investment portfolio severely depresses headline ROE and ROA ratios, tying up capital in market-exposed equities rather than operational growth.
- **Mitigation Strategies**: Dynamic pricing, optimization of costs, dual-sourcing for critical inputs, and a transition to less commoditized, technical advisory-driven sales.

## Shareholder and Corporate Information
- **Major Shareholders**: The ultimate parent company is Paints and General Industries Limited, with immediate parent CIC Holdings PLC owning 50.55% of Chemanex.
- **Public Float**: The public holding percentage is 36.25% (held by 1,708 shareholders), with a float-adjusted market capitalization of Rs. 928 Million. 
- **Dividends**: The company paid a massive combined cash and scrip dividend in the period leading to Q1 2026 (Rs. 7.50 per share effectively, consisting of Rs. 2.50 cash and Rs. 5.00 scrip), and recommended a subsequent final cash dividend of Rs. 2.50 per share.
- **Stock Price**: Share price climbed from Rs. 154.00 (Q1 2025) to Rs. 158.50 (Q1 2026).

## Investment Decision Indicators

**Strengths**:
- **Deep Valuation Discount**: Trading at Rs. 158.50 per share against a Net Asset Value of Rs. 260.40 per share (~0.6x P/B).
- **Exceptional Balance Sheet Strength**: Zero long-term debt and a massive, liquid equity portfolio backing the balance sheet.
- **Operational Turnaround**: Surging top-line revenue (+25% YoY) and net profit (+37% YoY) combined with improving working capital cycles.
- **Pricing Power**: Transitioning to specialized technical solutions insulates the company from pure commodity price wars.

**Weaknesses**:
- **Very Low ROE**: The return on equity (~3.88%) is highly depressed. While operations are profitable, the giant equity investment portfolio dilutes overall capital efficiency.
- **Short-Term Borrowing Reliance**: Despite huge equity investments, the company relies on bank overdrafts and short-term debt (Rs. 159 Million) to fund working capital.

**Opportunities**:
- Economic stabilization in Sri Lanka acts as a tailwind for domestic industrial output.
- Capturing emerging SME demand and expanding into the food/dairy additives space.

**Threats**:
- Volatility in the Sri Lankan Rupee and global chemical prices.
- Equity portfolio fluctuations (heavy exposure to the Sri Lankan stock market, particularly John Keells Holdings).

**Overall Assessment**:
The financial data presents a robust, highly capitalized, asset-rich business trading at a significant discount to its book value. The core operational business is growing rapidly with expanding margins due to smart management pivoting toward specialized products. However, investors must recognize that buying Chemanex is effectively buying a high-performing micro-cap chemical distributor attached to a massive equity investment fund. Evaluation should focus heavily on the investor's outlook on Chemanex's underlying equity holdings (like John Keells) alongside the core chemical distribution recovery.